Preoperative intralesional injection of triamcinolone acetonide for a large head and neck lymphangioma in a baby: a case report
Abstract: Lymphangiomas (LMs)
are uncommon congenital malformations of the lymphatic system, with an
estimated incidence of one in 2,000 to 4,000 live births.1 About half of these
lesions are diagnosed at birth, and by two years of age, 90% of those with
lesions have been diagnosed.2 Histologically, LMs are benign lesions; however,
they can pose a serious threat to the patient due to possible growth into
surrounding structures, sometimes causing life-threatening complications.
Treatment of large head and neck lymphangiomas in young infants is very
challenging, due to the risk of surgical complications. Further challenges
include the limited volume of blood loss that infants can tolerate, the lack of
the option for radiotherapy or radiosurgery, and the high chance of
life-threatening complications if the LM is not treated. Here, we report a case
of a two-month-old baby girl presenting with a large head and neck
lymphangioma. She was successfully treated with intralesional triamcinolone
acetonide injections, followed by surgical resection of the lesion.
Keywords: head lymphangioma;
young baby; triamcinolone acetonide; preoperative; intralesional injection
Author: Julius July, Sophie
Peeters
Journal Code: jpkedokterangg170175
